Deanxit triple viable capsule combined treatment of diarrhea-predominant irritable bowel syndrome clinical observation of 36 cases.docVIP

 PAGE \* MERGEFORMAT 7 Deanxit triple viable capsule combined treatment of diarrhea-predominant irritable bowel syndrome clinical observation of 36 cases [Abstract] Objective Force Concept Chadai new joint triple viable capsule treatment for diarrhea-predominant irritable bowel syndrome (IBS) effect, provide a reference for the treatment of IBS. Methods 76 patients with diarrhea-type IBS patients were divided into combined treatment group and 36 cases 40 patients a single treatment group. United were given Bifidobacterium deanxit + triple viable capsule, a single treatment group were given Bifidobacterium triple viable capsule, a course of 4 weeks. Comparison of the efficacy of the two groups. Results The treatment group markedly effective, efficient, and the total effective rate was 38.9%, 50.0%, 88.9%, respectively, were significantly higher than the single therapy group (22.5%, 37.5%, 40.0%), P lt;0.05. Conclusion new joint triple viable Daley Treating IBS with diarrhea have a good effect. [Keywords:] irritable bowel syndrome; Deanxit; Bifidobacterium triple viable capsule; joint; effect Irritable bowel syndrome (irritable bowel syndrome, IBS) is a group of abdominal pain, diarrhea, abnormal bowel movements characterized by symptoms such as intestinal functional diseases in recent years, studies have shown that abnormal neurological and psychological factors in the occurrence of visceral hypersensitivity in IBS , plays a key role in the regulation of [1]. Deanxit (Flupentixol melitracen) is a novel and can effectively improve the depression and anxiety medicine. I hospital in the past 3 years, the Joint Dual deanxit Qi triple viable capsule treatment for diarrhea IBS36 patients achieved good effect, the report is as follows. 1 Materials and Methods 1.1 The case group in our hospital from January 2007 to January 2010 were treated 76 patients with IBS with diarrhea, 36 cases were divided into combined treatment group, male 16, female 20 cases, a